Zhaojun Shen

1.0k citations
16 papers · 684 indexed · 1 hit paper · h-index 11

Zhaojun Shen

15 papers receiving 680 citations

Hit Papers

Molecular mechanisms of cisplatin resistance in cervical ...295201620262019202250100150200250

Peers

Zhaojun Shen
Comparison fields: 5 of 95
  • Cancer Research 184
  • Microbiology 69
  • Obstetrics and Gynecology 61
  • Reproductive Medicine 54
  • Oncology 163
Replace Leticia Rocha‐Zavaleta with:
Leticia Rocha‐Zavaleta Mexico
Zhentong Wei China
Lara Termini Brazil
Aki Yamashita Japan
Zacharias Fasoulakis Greece
Óscar Peralta-Zaragoza Mexico
Luo Yang China
Weiqing Wu China
Yi-Te Yo Taiwan
Zhaojun Shen relative to Leticia Rocha‐Zavaleta Mexico Leticia Rocha‐Zavaleta's profile →
Citations per field
00.5×1.5×2.3×
Leticia Rocha‐Zavaleta · 1×
Citations per year

Countries citing papers authored by Zhaojun Shen

Since Specialization
Citations

This map shows the geographic impact of Zhaojun Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhaojun Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhaojun Shen more than expected).

Fields of papers citing papers by Zhaojun Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhaojun Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhaojun Shen. The network helps show where Zhaojun Shen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Zhaojun Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Zhaojun Shen Line = papers co-authored together Zhaojun Shen links everyone, so they are left out of the graph.

All Works

16 of 16 papers shown
#Work
1 20240
2 20226
3 202015
4 201813
5 201818
6 20183
7 201717
8 201722
9 201654
10
Molecular mechanisms of cisplatin resistance in cervical cancerbreakdown →
2016295
11 20169
12 2016136
13 201661
14 20162
15 201515
16 201518

About Zhaojun Shen

Zhaojun Shen is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Toxicology, having authored 16 papers that have together received 684 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (3 papers), Uterine Myomas and Treatments (2 papers), Ectopic Pregnancy Diagnosis and Management (2 papers), Bioactive Compounds and Antitumor Agents (1 paper), Chemotherapy-induced organ toxicity mitigation (1 paper), Cancer Mechanisms and Therapy (1 paper), Genomics, phytochemicals, and oxidative stress (1 paper) and BRCA gene mutations in cancer (1 paper). The work is most often cited by research in Cancer Research (184 citations), Microbiology (69 citations) and Obstetrics and Gynecology (61 citations). Zhaojun Shen has collaborated with scholars based in China and United States. Frequent co-authors include Xueqiong Zhu, Haiyan Zhu, Hui Luo, Xiaoli Hu, Wenwen Zhang, Wenwen Zhang, Hui Luo, Lu‐Zhe Sun, Wenwen Zhang and Jun Wu. Their work appears in journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026